{
    "Trade/Device Name(s)": [
        "BioPlex 2200 HSV-1 and HSV-2 IgG Kit",
        "BioPlex 2200 Multi-Analyte Detection System"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K090409",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021429",
        "K021486",
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ",
        "MYF"
    ],
    "Summary Letter Date": "February 17, 2009",
    "Summary Letter Received Date": "February 18, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology"
    ],
    "Analyte(s)": [
        "HSV-1 IgG antibodies",
        "HSV-2 IgG antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Multiplex flow immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "System",
        "Instrument",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 HSV-1 and HSV-2 IgG Kit utilizing multiplex flow immunoassay to detect and differentiate IgG antibodies to HSV-1 and HSV-2 in serum and plasma",
    "Indications for Use Summary": "Qualitative detection and differentiation of IgG antibodies to HSV-1 and HSV-2 in human serum and EDTA or heparinized plasma, aiding the presumptive diagnosis of HSV-1 or HSV-2 infection in sexually active individuals and expectant mothers",
    "fda_folder": "Microbiology"
}